Pacira | PCRX - Pre Tax Profit


Pacira reported $571K in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Assertio Holdings USD -2.88M 648K Sep/2024
Astellas Pharma JPY 48.02B 85.93B Mar/2026
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Ironwood Pharmaceuticals USD 68.02M 30.2M Sep/2025
J&J USD 7.82B 2.86B Mar/2026
Ligand Pharmaceuticals USD 56.78M 84.36M Dec/2025
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Novo Nordisk DKK 33.8B 3.23B Jun/2025
Omeros USD -65.12M 21.27M Jun/2024
Pacira USD 571K 8.95M Dec/2025
Perrigo USD -1.33B 1.35B Dec/2025
Pfizer USD 5.18B 6.82B Mar/2026
Supernus Pharmaceuticals USD -5.95M 4.04M Mar/2026
Teva Pharmaceutical Industries USD 753M 662M Mar/2026
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025
Xoma USD 15.98M 24.58M Jun/2024
Zoetis USD 761M 126M Dec/2025